BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming

Area of Science:

• Cell biology
• Stem cell research
• Molecular biology

Background:

• Induced pluripotent stem cell (iPSC) generation is crucial for regenerative medicine but remains inefficient.
• The combination of OCT4, KLF4, SOX2, and MYC (OKSM) is commonly used for reprogramming.
• Apoptosis, or programmed cell death, is a known obstacle during the reprogramming process.

Purpose of the Study:

• To investigate the role of apoptosis in limiting reprogramming efficiency.
• To determine if inhibiting apoptosis can enhance iPSC generation.

Main Methods:

• Utilized mouse embryonic fibroblasts (MEFs) genetically engineered to lack the apoptosis mediators BAK and BAX.
• Compared reprogramming efficiency with and without MYC in these apoptosis-deficient MEFs.

Main Results:

• Reprogramming efficiency was significantly enhanced in MEFs lacking BAK and BAX, but only when MYC was included in the reprogramming cocktail (OKSM).
• The absence of MYC (OKS) in apoptosis-deficient MEFs did not show the same enhancement, indicating MYC's role in inducing apoptosis.
• Overexpression of MYC was identified as a major contributor to apoptosis during reprogramming.

Conclusions:

• Myc-induced apoptosis presents a significant roadblock to efficient iPSC reprogramming under OKSM conditions.
• Blocking apoptosis pathways, such as those mediated by BAK and BAX, can improve iPSC derivation.
• These findings suggest that targeting apoptosis could be a viable strategy to enhance iPSC generation for research and therapeutic applications.